---
title: "Reckitt self-care chief says AI boosts access to health information, strengthens consumer trust"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293745475.md"
description: "Reckitt's Self-Care chief highlights AI's role in enhancing health information access and consumer trust. The company positions self-care as a key healthcare pillar, focusing on prevention and symptom-led OTC demand. Strategy emphasizes consumer obsession, innovation, and end-to-end journey optimization across digital and physical channels. AI is leveraged for personalized, science-based guidance to build trust without replacing human decision-making, exemplified by campaigns for Gaviscon and Mucinex."
datetime: "2026-07-24T11:00:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293745475.md)
  - [en](https://longbridge.com/en/news/293745475.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293745475.md)
generator: "portal-rs"
---

# Reckitt self-care chief says AI boosts access to health information, strengthens consumer trust

-   Reckitt management flagged self-care as a growing pillar of healthcare as consumers shift toward prevention, monitoring, informed daily decisions. \* SVP Self Care Serra Bicak positioned OTC demand as symptom-led, citing a strategic push to build trust through clearer, science-based guidance. \* Strategy framed around consumer obsession, innovation, execution; focus on end-to-end journeys across search, pharmacies, e-commerce, social platforms. \* AI seen as a key channel for health information discovery; emphasis on personalization, simplification, trust rather than replacing human decision-making. \* Examples cited included Gaviscon “7 Symptoms” education campaign, Mucinex Kickstart positioned for faster morning relief to expand usage occasions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Reckitt Benckiser Group plc published the original content used to generate this news brief on July 24, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [RBGLY.US](https://longbridge.com/en/quote/RBGLY.US.md)
- [RKT.UK](https://longbridge.com/en/quote/RKT.UK.md)
- [RBGLD.US](https://longbridge.com/en/quote/RBGLD.US.md)

## Related News & Research

- [Reckitt unit Mead Johnson draws USD 400.42 million tenders for 2044 notes buyback](https://longbridge.com/en/news/295912622.md)
- [Reckitt Benckiser Bets on AI to Speed Innovation and Boost Growth](https://longbridge.com/en/news/286500374.md)
- [EXL earns dual Leader recognition in ISG’s 2026 Healthcare AI Report, cited for moving AI from pilots to enterprise scale | EXLS Stock News](https://longbridge.com/en/news/296492075.md)
- [TTEC Digital study finds AI adoption fails to cut costs as outdated CX operating models stall ROI](https://longbridge.com/en/news/296101755.md)
- [The Stocks Hiding in AI’s “Magical Spaces”](https://longbridge.com/en/news/296132093.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**